Join Growin Stock Community!

Liquidia corporationLQDA.US Overview

US StockHealthcare
(No presentation for LQDA)
My Watchlist

Ticker

Value

empty

There is no following symbol in this watchlist.

LQDA AI Insights

LQDA Overall Performance

LQDA AI Analysis & Strategy

AI Strategy

Browsing restrictions can be lifted for a fee.

LQDA Recent Performance

0.00%

Liquidia corporation

0.05%

Avg of Sector

-0.31%

S&P500

LQDA PowerScanner

Introduction >>

Power Squeeze

Surfing Trend

1 Day

1 Week

1 Month

LQDA Key Information

LQDA Financial Forecast

chart

Browsing restrictions can be lifted for a fee.

QuarterlyEPS ForecastQoQMaxMin
2026Q1
2026Q2
2026Q3
2026Q4
2027Q1

LQDA Profile

Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. It also distributes generic treprostinil injection in the United States. Liquidia Corporation was founded in 2004 and is headquartered in Morrisville, North Carolina.

Price of LQDA

LQDA FAQ

This disclaimer is provided by TradingValley Inc. and includes any messages, news, research, analysis, prices or other information provided by the Company's website, the application "Growin App" and other services provided through the Company's website. It is only general market information for educational and investment decision-making reference, and does not constitute any investment advice. View Growin Disclaimer

LQDA Earnings Table

Unit : USD

QTRNon-GAAP EPSEPS YoYEPS Surprise %SalesSales YoYSales Surprise %NPM
Current
2025Q4
2025Q3
2025Q2
2025Q1
METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
-1.40
PE Ratio (TTM)
-
Forward PE
-
PS Ratio (TTM)
38.99
PB Ratio
121.39
Price-to-FCF
-
METRIC
VALUE
vs. INDUSTRY
Gross Margin
89.11%
Net Margin
-176.04%
Revenue Growth (YoY)
343.41%
Profit Growth (YoY)
511.13%
3-Year Revenue Growth
157.98%
3-Year Profit Growth
176.33%
METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
-1.40
PE Ratio (TTM)
-
Forward PE
-
PS Ratio (TTM)
38.99
PB Ratio
121.39
Price-to-FCF
-
Gross Margin
89.11%
Net Margin
-176.04%
Revenue Growth (YoY)
343.41%
Profit Growth (YoY)
511.13%
3-Year Revenue Growth
157.98%
3-Year Profit Growth
176.33%
  • When is LQDA's latest earnings report released?

    The most recent financial report for Liquidia corporation (LQDA) covers the period of 2025Q3 and was published on 2025/09/30. This report is prepared according to IFRS/US GAAP standards and includes key financial indicators—Revenue, Profitability, Cash Flow, and Capital Structure. This information is essential for investors evaluating LQDA's short-term business performance and financial health. For the latest updates on LQDA's earnings releases, visit this page regularly.

  • What is the operating profit of LQDA?

    According to the latest financial report, Liquidia corporation (LQDA) reported an Operating Profit of 1.77M with an Operating Margin of 3.25% this period, representing a growth of 106.05% compared to the same period last year. Operating Profit reflects the company's core business efficiency and cost control, making it a key indicator for evaluating operational strength and profitability.

  • How is LQDA's revenue growth?

    In the latest financial report, Liquidia corporation (LQDA) announced revenue of 54.34M, with a Year-Over-Year growth rate of 1,121.72%. Revenue growth can be driven by product mix changes, market share expansion, price adjustments, or international market penetration. Investors should also monitor gross margin and regional revenue distribution for a comprehensive view of growth quality and sustainability.

  • How much debt does LQDA have?

    As of the end of the reporting period, Liquidia corporation (LQDA) had total debt of 199.18M, with a debt ratio of 0.72. Long-term debt comprises a higher/lower proportion. The level of financial leverage directly impacts the company's capital structure and interest coverage. If debt is high, pay attention to interest expenses and refinancing risks. Conversely, a low-leverage structure indicates greater risk tolerance but potentially less growth flexibility.

  • How much cash does LQDA have?

    At the end of the period, Liquidia corporation (LQDA) held Total Cash and Cash Equivalents of 161M, accounting for 0.58 of total assets. Both current and quick ratios indicate robust short-term debt repayment ability. High cash reserves typically mean the company has strong liquidity, supporting operational needs, expansion investments, or shareholder returns.

  • Does LQDA go with three margins increasing?

    In the latest report, Liquidia corporation (LQDA) did not achieve the “three margins increasing” benchmark, with a gross margin of 94.2%%, operating margin of 3.25%%, and net margin of -6.5%%. This demonstrates limited improvement in profitability, which is a key signal for fundamental analysis. Investors should consider margin trends alongside other financial indicators to assess LQDA's profit trajectory and future growth potential.

  • Is LQDA's EPS continuing to grow?

    According to the past four quarterly reports, Liquidia corporation (LQDA)'s earnings per share (EPS) shows a steady growth trend, with the latest EPS at -0.04. If EPS continues to rise due to revenue growth and cost optimization, it can support P/E valuation recovery and attract long-term investors.

  • What is the FCF of LQDA?

    Liquidia corporation (LQDA)'s Free Cash Flow (FCF) for the period is -10.68M, calculated as Operating Cash Flow minus Capital Expenditures, representing a rise of 60.19% compared with the previous period. Positive FCF growth provides stable funding for dividends, debt repayment, or strategic acquisitions, and is an important measure of true profitability and shareholder return potential.

  • What are the PEG ratio and PE ratio of LQDA?

    The latest valuation data shows Liquidia corporation (LQDA) has a Price-To-Earnings (PE) ratio of -18.01 and a Price/Earnings-To-Growth (PEG) ratio of 1.52. A PEG below 1 usually suggests the market is underestimating growth potential, while a PEG above 1 indicates high growth expectations are already priced in. Investors should conduct a comprehensive valuation by considering historical growth, market forecasts, and industry cycles.